J Boutin
Overview
Explore the profile of J Boutin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cullot G, Boutin J, Fayet S, Prat F, Rosier J, Cappellen D, et al.
Nat Commun
. 2023 Jul;
14(1):4072.
PMID: 37429857
The CRISPR-Cas9 system has revolutionized our ability to precisely modify the genome and has led to gene editing in clinical applications. Comprehensive analysis of gene editing products at the targeted...
2.
Sallee J, Abrahamsen E, Allaigre C, Auger M, Ayres H, Badhe R, et al.
Philos Trans A Math Phys Eng Sci
. 2023 May;
381(2249):20220056.
PMID: 37150205
The Southern Ocean greatly contributes to the regulation of the global climate by controlling important heat and carbon exchanges between the atmosphere and the ocean. Rates of climate change on...
3.
Boutin J, Rosier J, Cappellen D, Prat F, Toutain J, Pennamen P, et al.
Nat Commun
. 2021 Aug;
12(1):4922.
PMID: 34389729
CRISPR-Cas9 is a promising technology for gene therapy. However, the ON-target genotoxicity of CRISPR-Cas9 nuclease due to DNA double-strand breaks has received little attention and is probably underestimated. Here we...
4.
Bedel A, Boutin J, Amintas S, Lamrissi-Garcia I, Rousseau B, Poglio S, et al.
Biochem Biophys Res Commun
. 2021 Jul;
569:23-28.
PMID: 34216994
Intravenous injections of human hematopoietic stem cells (hHSCs) is routinely used in clinic and for modeling hematopoiesis in mice. However, unspecific dilution in vascular system and non-hematopoietic organs challenges engraftment...
5.
Branchereau J, Timsit M, Neuzillet Y, Bessede T, Thuret R, Gigante M, et al.
World J Urol
. 2017 Oct;
36(1):105-109.
PMID: 29058024
Purpose: Urolithiasis is rare among renal transplant recipients and its management has not been clearly defined. Methods: This multicentre retrospective study was organised by the Comité de Transplantation de l'Association...
6.
Guleryuz K, Doerfler A, Bensadoun H, Boutin J, Bouye S, Chambade D, et al.
Prog Urol
. 2015 Nov;
25(13):766.
PMID: 26544299
No abstract available.
7.
May A, Bergot C, Boutin J, Branchereau J, Karam G, Bruyere F
Prog Urol
. 2015 Nov;
25(13):724.
PMID: 26544214
No abstract available.
8.
Pradere B, Benoit T, May A, Peyronnet B, Sallusto F, Faivre dArcier B, et al.
Prog Urol
. 2015 Nov;
25(13):723-4.
PMID: 26544212
No abstract available.
9.
Bruban V, Feldman J, Greney H, Dontenwill M, Schann S, Jarry C, et al.
Br J Pharmacol
. 2001 May;
133(2):261-6.
PMID: 11350862
The hypotensive effect of imidazoline-like drugs, such as clonidine, was first attributed to the exclusive stimulation of central alpha2-adrenoceptors (alpha2ARs). However, a body of evidence suggests that non-adrenergic mechanisms may...
10.
Boucher E, Guyader D, Jacquelinet S, Andre P, Mendler M, Turlin B, et al.
Dig Liver Dis
. 2000 Sep;
32(1):29-33.
PMID: 10975752
Aims: This prospective randomized trial was carried out in order to determine whether the long-term administration of ursodeoxycholic acid after discontinuation of interferon had any beneficial effect on the clinical...